. "Appendix D-7: The Prospects for Immunizing Against
Mycobacterium leprae." New Vaccine Development: Establishing
Priorities: Volume II, Diseases of Importance in Developing
Countries. Washington, DC: The National Academies Press, 1986.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly
to HTML. Please use the page image as the authoritative form to
ensure accuracy. New Vaccine Development: Establishing
Priorities, Volume II, Diseases of Importance in Developing
Countries this basis, the annual global incidence would be about
1.06 million cases. For the purposes of this assessment, all new
cases are assumed to have some clinical symptoms that result in
some permanent (but possibly mild) disability (category D)—such
as minor neurological deficit. The proportion of cases in
children (14 years of age and younger) is approximately 20
percent of detected cases (17.4 to 29 percent; Noordeen,
personal communication, 1984) and is probably higher for